Literature DB >> 32580793

Tricuspid valvuloplasty for isolated tricuspid regurgitation in children.

Guanxi Wang1, Kai Ma1, Kunjing Pang2, Sen Zhang1, Lei Qi1, Yang Yang1, Zicong Feng1, Fengqun Mao1, Jianhui Yuan1, Hao Zhang3, Shoujun Li1.   

Abstract

BACKGROUND: Isolated congenital tricuspid regurgitation other than Ebstein's anomaly was rare especially for children. The objective of this study was to investigate the clinical characteristics and to assess the results of tricuspid valvuloplasty for children with isolated tricuspid regurgitation.
METHODS: From January 2010 to June 2019, 10 consecutive patients with isolated tricuspid regurgitation who were unresponsive to drug therapy underwent tricuspid valvuloplasty in our hospital. Patients' clinical data were analysed retrospectively.
RESULTS: Mean age at operation was 48.5 ± 31.0 (range: 9-106) months and mean weight at operation was 16.1 ± 6.9 (range: 8.6-33.0) kg. All patients presented severe isolated tricuspid regurgitation. According to pathological lesions, the main causes accounted for chordae tendinea rupture (3/10), leaflet cleft (2/10), mal-connected chordal tendinea to leaflets (2/10), elongated chordae (1/10) and chordae absent (1/10), and severe anterior leaflet dysplasia (1/10). Individualised tricuspid valvuloplasty was adapted to all of them successfully. Post-operative echocardiography showed no tricuspid regurgitation in two patients and mild regurgitation in eight patients. The cardiothoracic ratios on their chest roentgenograms decreased from 0.59 ± 0.05 to 0.54 ± 0.05. At the latest follow-up (50.4 ± 47.2 months), echocardiography showed that mild to moderate tricuspid regurgitation in seven patients, moderate tricuspid regurgitation in three patients, and no patient with severe tricuspid regurgitation. All patients were in NYHA functional class I.
CONCLUSIONS: For patients with isolated tricuspid regurgitation who were not well responsive to drug therapy, individualised tricuspid valve repair can achieve an excellent result.

Entities:  

Keywords:  CHDs; Tricuspid regurgitation; leaflet cleft; tricuspid valvuloplasty

Mesh:

Year:  2020        PMID: 32580793     DOI: 10.1017/S104795112000150X

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  1 in total

1.  Outcomes and risk analysis after tricuspid valve surgery for non-Ebstein 2-ventricle congenital tricuspid valve diseases.

Authors:  David Blitzer; Ismail Bouhout; Eliana Al Haddad; Matthew Lewis; Kanwal Farooqi; Amee Shah; Noa Zemer-Wassercug; Harsimran Singh; Brett Anderson; Emile Bacha; David Kalfa
Journal:  JTCVS Open       Date:  2022-07-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.